Logos Global Management LP

Name: Logos Global Management LP: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in San Francisco, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1792126.

Share this page

Link

Story card, 1080 × 1920

Reported value$2.32bn
Positions68

Holdings: 68 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

Logos Global Management LP, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Change on the quarter before
Erasca IncERAS	COM	29479A108	223	9.6%	12,150,000	Added+1,000,000
Abivax SAABVX	SPONSORED ADS	00370M103	136	5.9%	1,024,000	Added+349,000
Revolution Medicines IncRVMD	COM	76155X100	131	5.6%	700,000	Reduced−1,300,000
Ideaya Biosciences IncIDYA	COM	45166A102	112	4.8%	3,000,000	Reduced−450,000
Biontech SEBNTX	SPONSORED ADS	09075V102	94.4	4.1%	1,015,000	New+1,015,000
Vera Therapeutics IncVERA	CL A	92337R101	94.4	4.1%	2,200,000	New+2,200,000
Tango Therapeutics IncTNGX	COM	87583X109	89.1	3.8%	2,850,000	Reduced−150,000
Praxis Precision Medicines IPRAX	COM NEW	74006W207	87.0	3.7%	260,000	Reduced−25,000
Celldex Therapeutics Inc NewCLDX	COM NEW	15117B202	78.1	3.4%	2,100,000	Added+1,650,000
Dianthus Therapeutics IncDNTH	COM	252828108	78.0	3.4%	800,000	Added+400,000
CG Oncology IncCGON	COM	156944100	71.1	3.1%	1,000,000	Added+425,000
Disc Medicine IncIRON	COM	254604101	64.0	2.8%	875,000	Added+315,000
Maze Therapeutics IncMAZE	COM	578784100	57.7	2.5%	1,935,000	Added+700,000
Dyne Therapeutics IncDYN	COM	26818M108	56.6	2.4%	2,550,000	Added+1,150,000
Moonlake ImmunotherapeuticsMLTX	CLASS A ORD	61559X104	52.1	2.2%	2,675,000	Added+1,175,000
Ocular Therapeutix IncOCUL	COM	67576A100	52.0	2.2%	5,300,000	Added+1,450,000
Design Therapeutics IncDSGN	COM	25056L103	43.4	1.9%	3,000,000	Added+1,050,000
Olema Pharmaceuticals IncOLMA	COM	68062P106	40.1	1.7%	3,208,875	Unchanged
Belite Bio IncBLTE	SPONSORED ADS	07782B104	38.5	1.7%	250,000	New+250,000
Achieve Life Science IncACHV	COM	004468500	35.4	1.5%	5,425,000	New+5,425,000
Trevi Therapeutics IncTRVI	COM	89532M101	35.1	1.5%	1,880,000	Reduced−520,000
Cogent Biosciences IncCOGT	COM	19240Q201	34.8	1.5%	900,000	New+900,000
Arrivent Biopharma IncAVBP	COM	04272N102	34.7	1.5%	1,000,000	Added+650,000
Crescent Biopharma Inc.	COM	G2545C104	34.2	1.5%	1,900,000	Added+1,417,500
Compass Pathways plcCMPS	SPONSORED ADS	20451W101	31.8	1.4%	2,250,000	New+2,250,000
Mineralys Therapeutics IncMLYS	COM	603170101	28.3	1.2%	1,050,000	New+1,050,000
Replimune Group IncREPL	COM	76029N106	27.7	1.2%	2,500,000	New+2,500,000
Xenon Pharmaceuticals IncXENE	COM	98420N105	27.2	1.2%	450,000	Unchanged
Structure Therapeutics IncGPCR	SPONSORED ADS	86366E106	26.8	1.2%	500,000	Unchanged
Immunovant IncIMVT	COM	45258J102	25.6	1.1%	665,000	Reduced−410,000
Jade Biosciences IncJBIO	COM NEW	008064206	25.0	1.1%	1,125,000	Added+725,000
Enliven Therapeutics IncELVN	COM	29337E102	23.6	1.0%	465,000	Reduced−75,000
Veradermics IncMANE	COMMON STOCK	922967104	22.1	1.0%	180,000	Added+155,000
Avalo Therapeutics IncAVTX	COM NEW	05338F306	21.3	0.9%	1,150,000	Added+850,000
Arcus Biosciences IncRCUS	COM	03969F109	20.0	0.9%	650,000	Reduced−550,000
Summit Therapeutics IncSMMT	COM	86627T108	19.7	0.8%	1,350,000	New+1,350,000
Immunocore Holdings plcIMCR	ADS	45258D105	19.1	0.8%	600,000	Reduced−900,000
LB Pharmaceuticals IncLBRX	COM SHS	50180M108	19.0	0.8%	585,000	Reduced−330,000
Minerva Neurosciences IncNERV	COM NEW	603380205	18.3	0.8%	3,288,777	Added+73,777
Faeth Therapeutics IncFTH	COM NEW	81728A207	18.1	0.8%	722,020	Added+692,020
Crispr Therapeutics AG	NAMEN AKT	H17182108	16.4	0.7%	300,000	New+300,000
DBV Technologies S aDBVT	SPONSORED ADS	23306J309	15.0	0.6%	915,000	New+915,000
Parabilis Medicines IncPBLS	COM	698955101	14.4	0.6%	525,000	New+525,000
Rhythm Pharmaceuticals IncRYTM	COM	76243J105	13.9	0.6%	125,000	Reduced−325,000
VOR Biopharma IncVOR	COM NEW	929033207	12.0	0.5%	650,000	Reduced−100,000
Scholar Rock HLDG CorpSRRK	COM	80706P103	11.0	0.5%	200,000	New+200,000
Immix Biopharma IncIMMX	COM	45258H106	10.3	0.4%	1,000,000	Reduced−225,000
Q32 Bio IncQTTB	COM	746964105	10.2	0.4%	800,000	New+800,000
Odyssey Therapeutics IncODTX	COMMON STOCK	67613T104	9.8	0.4%	521,736	New+521,736
Annexon IncANNX	COM	03589W102	8.6	0.4%	1,500,000	New+1,500,000
Editas Medicine IncEDIT	COM	28106W103	7.2	0.3%	2,222,000	New+2,222,000
Relay Therapeutics IncRLAY	COM	75943R102	6.5	0.3%	350,000	Reduced−400,000
Acadia Pharmaceuticals IncACAD	COM	004225108	6.3	0.3%	250,000	Reduced−500,000
Amylyx Pharmaceuticals IncAMLX	COM	03237H101	6.3	0.3%	350,000	Reduced−350,000
Cybin Inc	COM NEW	23256X407	5.0	0.2%	750,000	New+750,000
Onkure Therapeutics IncOKUR	COM CL A	68277Q105	4.4	0.2%	963,855	New+963,855
Tenax Therapeutics IncTENX	COM NEW	88032L605	4.4	0.2%	300,000	Reduced−325,000
Definium Therapeutics IncDFTX	COM SHS	24477V105	3.8	0.2%	80,000	New+80,000
Unicycive Therapeutics IncUNCY	COM NEW	90466Y202	2.2	<0.1%	473,563	Unchanged
Palatin Technologies IncPTN	COM NEW	696077601	1.4	<0.1%	130,000	Reduced−10,000
Uniqure NV	SHS	N90064101	1.4	<0.1%	30,000	New+30,000
Jatt II Acquisition Corp	ORD SHS	G50765109	1.1	<0.1%	100,000	New+100,000
Research Alliance Corp III	ORD SHS CL A	G75226103	1.1	<0.1%	100,000	New+100,000
Aclaris Therapeutics IncACRS	COM	00461U105	1.1	<0.1%	200,000	Reduced−300,000
Longeveron Inc	CL A NEW	54303L203	0.9	<0.1%	1,287,000	New+1,287,000
Fractyl Health Inc	COM	35168W103	0.8	<0.1%	1,000,000	Unchanged
Septerna IncSEPN	COM	81734D104	0.8	<0.1%	23,548	Unchanged
Amanat Acquisition Corp	CL A ORD	G0375M101	0.5	<0.1%	50,000	New+50,000

Sold out: 23 positions

Held at the end of the quarter before and not reported this quarter.

Logos Global Management LP, positions sold out
Issuer	Class	CUSIP	Weight	Put or call	Change on the quarter before
Alkermes plc	SHS	G01767105	0.0%		Sold out−350,000
Avalo Therapeutics IncAVTX	COM NEW	05338F306	0.0%	Call	Sold out−1,000,000
Biogen IncBIIB	COM	09062X103	0.0%		Sold out−200,000
Centessa Pharmaceuticals plc	SPONSORED ADS	152309100	0.0%		Sold out−2,125,000
Compass Therapeutics IncCMPX	COM	20454B104	0.0%		Sold out−3,150,000
Corvus Pharmaceuticals IncCRVS	COM	221015100	0.0%		Sold out−450,000
Cytokinetics IncCYTK	COM NEW	23282W605	0.0%		Sold out−875,000
Enliven Therapeutics IncELVN	COM	29337E102	0.0%	Call	Sold out−500,000
Ibio IncIBIO	COM NEW	451033708	0.0%		Sold out−1,300,000
Janux Therapeutics IncJANX	COM	47103J105	0.0%		Sold out−1,000,000
Madrigal Pharmaceuticals IncMDGL	COM	558868105	0.0%		Sold out−85,000
Meiragtx Holdings plc	COM	G59665102	0.0%		Sold out−700,000
Mirum Pharmaceuticals IncMIRM	COM	604749101	0.0%		Sold out−200,000
Newamsterdam Pharma Company	ORDINARY SHARES	N62509109	0.0%		Sold out−600,000
Oric Pharmaceuticals IncORIC	COM	68622P109	0.0%		Sold out−950,000
Pharvaris N V	COM	N69605108	0.0%		Sold out−65,000
Soleno Therapeutics Inc	COM	834203309	0.0%		Sold out−250,000
Terns Pharmaceuticals Inc	COM	880881107	0.0%		Sold out−1,500,000
Terns Pharmaceuticals Inc	COM	880881107	0.0%	Call	Sold out−500,000
Tyra Biosciences IncTYRA	COM	90240B106	0.0%		Sold out−850,000
United Therapeutics Corp DelUTHR	COM	91307C102	0.0%		Sold out−80,000
Vaxcyte IncPCVX	COM	92243G108	0.0%		Sold out−300,000
Verastem IncVSTM	COM NEW	92337C203	0.0%		Sold out−1,000,000

Source: SEC EDGAR, Form 13F-HR, accession 0001172661-26-003529 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.